← Leaderboards
Alejandro Marin Lopez
L2 Diagnostics, Llc
$1,261,637
Attributed
$2,241,487
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $980.2K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,241,487 · 2
By mechanism
R42$1,959,701 · 1
R41$281,786 · 1
Top collaborators
- Erol Fikrig2 shared
Most similar at L2 Diagnostics, Llc
Same institution · by research overlap
- Michel Ledizet$12,357,647
- Raymond A Koski$5,972,928
- Fengwei Bai$1,230,098
- Alan Gordon Sutherland$2,685,002
Others in their field
Other Rising Stars on “Interleukin-10”
- Suma Babu · Massachusetts General Hospital$9,673,541
- Sabrina Paganoni · Massachusetts General Hospital$9,673,541
- Amar Nijagal · University Of California, San Francisco$3,176,680
- Heather Leigh Herd Gustafson · Seattle Children'S Hospital$2,399,099
- Edy Yong Kim · Brigham And Women'S Hospital$2,367,024
- Christa Joy Nehs · Massachusetts General Hospital$2,137,648
Research focus
Interleukin-10Phase 2 StudyImmuneInfectionInterleukin-6PathogenFlavivirusIl8 GeneImmune ResponseImmunogenicityInterleukin-4Interleukin-5Mouse ModelAntigensArbovirusesDoseGranulocyte-Macrophage Colony-Stimulating FactorBiteAntibodiesBloodCd8-Positive T-LymphocytesImmunizeInterleukin-2Play
Grant awards (3)
A viral vector-based vaccine to induce humoral and cellular immune protection against Powassan virus in a tick transmission model$281,786
R41 · FY2025 · AI · contact PI
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1$980,219
R42 · FY2024 · AI
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1$979,482
R42 · FY2023 · AI